EPA:VETO - Euronext Paris - Matif - FR0004186856 - Common Stock - Currency: EUR
VETO gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 52 industry peers in the Pharmaceuticals industry. VETO is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. VETO has a valuation in line with the averages, but it does not seem to be growing.
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | 7.89% | ||
ROE | 10.19% | ||
ROIC | 9.22% |
Industry Rank | Sector Rank | ||
---|---|---|---|
OM | 14.24% | ||
PM (TTM) | 10.88% | ||
GM | 50.82% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0.02 | ||
Debt/FCF | 0.31 | ||
Altman-Z | 5.87 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Current Ratio | 2.98 | ||
Quick Ratio | 2.18 |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 15.98 | ||
Fwd PE | 15.02 |
Industry Rank | Sector Rank | ||
---|---|---|---|
P/FCF | 13.88 | ||
EV/EBITDA | 6.89 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | 1.11% |
EPA:VETO (7/18/2025, 7:00:00 PM)
79.6
-0.5 (-0.62%)
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | 1.11% |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 15.98 | ||
Fwd PE | 15.02 | ||
P/S | 1.75 | ||
P/FCF | 13.88 | ||
P/OCF | 11.02 | ||
P/B | 1.64 | ||
P/tB | 2.65 | ||
EV/EBITDA | 6.89 |
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | 7.89% | ||
ROE | 10.19% | ||
ROCE | 12.75% | ||
ROIC | 9.22% | ||
ROICexc | 14.02% | ||
ROICexgc | 31.25% | ||
OM | 14.24% | ||
PM (TTM) | 10.88% | ||
GM | 50.82% | ||
FCFM | 12.64% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0.02 | ||
Debt/FCF | 0.31 | ||
Debt/EBITDA | 0.1 | ||
Cap/Depr | 57.74% | ||
Cap/Sales | 3.28% | ||
Interest Coverage | 159.67 | ||
Cash Conversion | 79.9% | ||
Profit Quality | 116.12% | ||
Current Ratio | 2.98 | ||
Quick Ratio | 2.18 | ||
Altman-Z | 5.87 |